Prevail Therapeutics Inc. SEC Filings

Filed On	Filing
16 Feb 2021	SC 13G/A
16 Feb 2021	SC 13G/A
12 Feb 2021	SC 13G/A
12 Feb 2021	SC 13G/A
01 Feb 2021	15-12B
29 Jan 2021	SC 13G
29 Jan 2021	AMENDMENT NO. 1
26 Jan 2021	EFFECT
26 Jan 2021	Form 4: Orbimed Advisors Llc, Director and 1 other Disposed of 13,822,463 shares (Tender Offer)
26 Jan 2021	Form 4: Carson William H., Director Disposed of 34,000 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jan 2021	Form 4: Nader Francois, Director Disposed of 23,747 shares (Tender Offer) · Disposed of 182,447 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jan 2021	Form 4: Nussbaum Ran, Director Disposed of 1,576,881 shares (Tender Offer) · Disposed of 17,000 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jan 2021	Form 4: Gordon Carl L, Director Disposed of 13,822,463 shares (Tender Offer) · Disposed of 17,000 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jan 2021	Form 4: Thompson Peter A., Director Disposed of 13,822,463 shares (Tender Offer) · Disposed of 17,000 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jan 2021	Form 4: Abeliovich Asa, Director Disposed of 2,385,756 shares (Tender Offer) · Disposed of 1,757,900 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jan 2021	Form 4: Adams Timothy M, Director Disposed of 49,400 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jan 2021	Form 4: Dai Yong, Chief Technology Officer Disposed of 370,239 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jan 2021	Form 4: Hefti Franz, Chief Development Officer Disposed of 388,939 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jan 2021	Form 4: Kaplan Brett, Chief Financial Officer Disposed of 506,569 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jan 2021	Form 4: Minkow Emily, Chief Business Officer Disposed of 13,000 shares (Tender Offer) · Disposed of 416,749 Stock Option (Right to Buy) (Disposition to Issuer)

Comments